Cargando…
A Novel Neuraminidase Virus-Like Particle Vaccine Offers Protection Against Heterologous H3N2 Influenza Virus Infection in the Porcine Model
Influenza A viruses (IAVs) pose a global health threat, contributing to hundreds of thousands of deaths and millions of hospitalizations annually. The two major surface glycoproteins of IAVs, hemagglutinin (HA) and neuraminidase (NA), are important antigens in eliciting neutralizing antibodies and p...
Autores principales: | Pliasas, Vasilis C., Menne, Zach, Aida, Virginia, Yin, Ji-Hang, Naskou, Maria C., Neasham, Peter J., North, J. Fletcher, Wilson, Dylan, Horzmann, Katharine A., Jacob, Joshy, Skountzou, Ioanna, Kyriakis, Constantinos S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300842/ https://www.ncbi.nlm.nih.gov/pubmed/35874791 http://dx.doi.org/10.3389/fimmu.2022.915364 |
Ejemplares similares
-
Heterologous prime-boost H1N1 vaccination exacerbates disease following challenge with a mismatched H1N2 influenza virus in the swine model
por: Pliasas, Vasilis C., et al.
Publicado: (2023) -
Novel Vaccine Technologies in Veterinary Medicine: A Herald to Human Medicine Vaccines
por: Aida, Virginia, et al.
Publicado: (2021) -
Editorial: Novel Vaccine Technologies in Animal Health
por: Pliasas, Vasilis C., et al.
Publicado: (2022) -
NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines?
por: Krammer, Florian, et al.
Publicado: (2018) -
Inactivated Whole Virus Particle Influenza Vaccine Induces Anti-Neuraminidase Antibodies That May Contribute to Cross-Protection against Heterologous Virus Infection
por: Handabile, Chimuka, et al.
Publicado: (2022)